【Media】Yomiuri Shimbun article on the effect of Cybernics Treatment on ALS Patients

The Yomiuri Shimbun Online posted an article on the report by a team from the National Hospital Organization Niigata Hospital. The team conducted Cybernics Treatment for patients with amyotrophic lateral sclerosis (ALS) who have difficulty walking. As a result of Cybernics Treatment with Medical HAL Lower Limb Type, the distance the patient could walk on their own increased by 25% on average. The research was published in an international medical journal.

【Link to published article】
ALS Patients’ ability to walk on their own improved by 25%…rehabilitation with Robot Suit confirmed to affect patients with progressed intractable diseases (Yomiuri Shimbun, Apr. 01, 2022)
(Published online at https://www.yomiuri.co.jp/medical/20220401-OYT1T50140/)

Excerpts from the article
The patients’ average distance walked on their own in 2 minutes increased by 25%. The more intensively the patients worked on it every few days, the more significant the improvement. It is believed that the neural connections were regenerated by repeated walking without putting strain on the body.
The use of HAL Lower Limb Type is spreading, with 83 units installed in 59 facilities nationwide as of last year. Dr. Takashi Nakajima, director of Niigata Hospital, said, “Other than HAL, there was no other treatment proven to improve gait function. Combining HAL with drugs has the potential to restore function in an ideal way.
Yoshiki Sekijima, Professor of Neurology at Shinshu University, says, “In addition to intractable neurological diseases that cause loss of motor function, there may be potential applications in gait rehabilitation for spinal cord injury, stroke, and muscle weakness due to aging.”

【Reference】
July 26, 2021【News】Details report of the investigator-initiated clinical trial of Medical HAL for neuromuscular disease patients published in an international medical journal
https://www.cyberdyne.jp/english/company/PressReleases_detail.html?id=11065